Liminatus Pharma, Inc.
LIMNW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001971387
No open-market purchases or sales by Liminatus Pharma, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $90.1K in total; no superinvestor holds it.
Other share classesLIMN
13F holders, Q2 2026
Institutional positions in Liminatus Pharma, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q1 2026
- Shares held
- 1.57M
- −14.7K (−0.9%) vs. Q1 2026
- Total value
- $90.1K
- +$17.5K (+24.1%) vs. Q1 2026
- New holders
- 2
- 0 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIMNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $90.1K |
| Q1 2026 | 21 | $72.6K |
| Q4 2025 | 25 | $95.0K |
| Q3 2025 | 27 | $400.3K |
| Q2 2025 | 26 | $837.0K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Liminatus Pharma, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HGC Investment Management Inc. | 1,250 | $94 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 6,250 | $318 | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 4,507 | $338 | 0.00% | 00.0% | Unchanged |
| Flow Traders U.S. LLC | 13,110 | $1.00K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,805 | $1.00K | 0.00% | +10,805 | New |
| Wolverine Asset Management LLC | 13,976 | $1.05K | 0.00% | −25,397−64.5% | Reduced |
| Susquehanna International Group, LLP | 17,562 | $1.32K | 0.00% | +17,562 | New |
| GTS Securities LLC | 20,929 | $1.57K | 0.00% | −100−0.5% | Reduced |
| Limestone Investment Advisors LP | 22,562 | $1.69K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 24,274 | $1.82K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 30,000 | $1.98K | 0.00% | −17,500−36.8% | Reduced |
| Blue Owl Capital Holdings LP | 50,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Arena Capital Advisors, LLC- CA | 29,166 | $2.19K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 29,961 | $2.25K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 35,100 | $2.63K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 83,353 | $2.93K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 122,688 | $6.26K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 111,745 | $8.38K | 0.00% | 00.0% | Unchanged |
| Moore Capital Management, LP | 125,000 | $9.38K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 233,761 | $11.9K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 268,199 | $13.7K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 319,510 | $16.3K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |